-
Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry：The EuroCTO (CASTLE) ScoreSzijgyarto Z, Rampat R, Werner GS et al. -
Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary DiseaseM Qintar, KH Humphries, JE Park et al.
-
Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art ReviewLA Sposato , MJ Hilz , S Aspberg et al.
-
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?Wehner GJ, Jing L, Haggerty CM et al.
-
Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO RegistryJT Saxon, JA Grantham , AC Salisbury et al.
-
Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunctionF Leuschner, M Nahrendorf et al.
-
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyCT January, LS Wann, H Calkins et al.
-
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting StentsYL Han, B Xu, NeoVas Randomized Controlled Trial Investigators
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
